Cécile Kerloëguen

910 total citations
5 papers, 64 citations indexed

About

Cécile Kerloëguen is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Cécile Kerloëguen has authored 5 papers receiving a total of 64 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Hematology. Recurrent topics in Cécile Kerloëguen's work include Multiple Sclerosis Research Studies (3 papers), Viral Infections and Immunology Research (2 papers) and Fungal Plant Pathogen Control (1 paper). Cécile Kerloëguen is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Viral Infections and Immunology Research (2 papers) and Fungal Plant Pathogen Control (1 paper). Cécile Kerloëguen collaborates with scholars based in Switzerland, United States and Germany. Cécile Kerloëguen's co-authors include Bernard Canaud, Ulrich Beyer, Pedro Aljama, J. Braun, Francesco Locatelli, Giuseppe Villa, G. Mingardi, Peter G. Kerr, Bruno Van Vlem and Alan W. McMahon and has published in prestigious journals such as Neurology and Nephrology Dialysis Transplantation.

In The Last Decade

Cécile Kerloëguen

4 papers receiving 62 citations

Peers

Cécile Kerloëguen
A. Essaian Russia
Fabio Lizzi Germany
Diogo Belo United States
Houda Kanoun Tunisia
A. Mahfoud Tunisia
Erin Law Switzerland
Rebecca Hudson Australia
A. Essaian Russia
Cécile Kerloëguen
Citations per year, relative to Cécile Kerloëguen Cécile Kerloëguen (= 1×) peers A. Essaian

Countries citing papers authored by Cécile Kerloëguen

Since Specialization
Citations

This map shows the geographic impact of Cécile Kerloëguen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Kerloëguen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Kerloëguen more than expected).

Fields of papers citing papers by Cécile Kerloëguen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Kerloëguen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Kerloëguen. The network helps show where Cécile Kerloëguen may publish in the future.

Co-authorship network of co-authors of Cécile Kerloëguen

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Kerloëguen. A scholar is included among the top collaborators of Cécile Kerloëguen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Kerloëguen. Cécile Kerloëguen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Delgado, Silvia, Mitzi Williams, Morten Bagger, et al.. (2021). Comparable Ofatumumab Treatment Outcomes in Patients across Racial/Ethnic Groups in the ASCLEPIOS I/II and APOLITOS studies (4139). Neurology. 96(15_supplement). 2 indexed citations
2.
Bar‐Or, Amit, J. de Sèze, Jorge Correale, et al.. (2021). Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis (RMS) Patients from the Phase 3 ASCLEPIOS I and II Trials (1300). Neurology. 96(15_supplement). 9 indexed citations
3.
Fox, Edward, Cécile Kerloëguen, Linda Mancione, et al.. (2021). Adherence and Compliance with Subcutaneous Administration of Ofatumumab in Relapsing Multiple Sclerosis (4521). Neurology. 96(15_supplement).
4.
Kappos, Ludwig, Amit Bar‐Or, Jeffrey A. Cohen, et al.. (2019). Baseline Characteristics of Patients with Relapsing Multiple Sclerosis in ASCLEPIOS Phase 3 Trials of Ofatumumab Versus Teriflunomide (P3.2-096). Neurology. 92(15_supplement). 1 indexed citations
5.
Canaud, Bernard, G. Mingardi, J. Braun, et al.. (2008). Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrology Dialysis Transplantation. 23(11). 3654–3661. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026